Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine

被引：8

作者：

Pavithran, K ^{[1
]}

Doval, DC ^{[1
]}

机构：

[1] Rajiv Gandhi Canc Inst & Res, New Delhi 110085, India

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2005年 / 28卷 / 02期

关键词：

papillary thyroid carcinoma; I-131; chronic myeloid leukemia; secondary CML;

D O I：

10.1097/01.coc.0000143845.79889.33

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Leukemia as a second malignancy after treatment of thyroid cancer is rare. Most cases reported in the literature-have occurred after cumulative doses higher than 800 mCi and it is most commonly acute leukemias. We report a case of chronic myeloid leukemia (CML) occurring in a 40-year-old man 14 years after treatment of papillary thyroid carcinoma. Our patient had the longest interval between the diagnosis of CML and administration of I-131.

引用

页码：216 / 216

页数：1

共 50 条

[41] Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial
Anna M Sawka
Sharon Straus
James D Brierley
Richard W Tsang
Lorne Rotstein
Gary Rodin
Amiram Gafni
Shereen Ezzat
Lehana Thabane
Kevin E Thorpe
David P Goldstein
Trials, 11
[42] Association between the increase in incidence of papillary thyroid carcinoma in Crete and exposure to radioactive agents
Prokopakis, E. P.
Kaprana, A.
Karatzanis, A.
Velegrakis, G. A.
Melissas, J.
Chalkiadakis, G.
ACTA OTORHINOLARYNGOLOGICA ITALICA, 2018, 38 (04) : 310 - 315
[43] Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease
Yunusa, Garba H.
Kotze, Tessa
Brink, Anita
ANNALS OF AFRICAN MEDICINE, 2014, 13 (02) : 91 - 94
[44] Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma
Jeong G.-C.
Song M.
Park H.J.
Min J.-J.
Bom H.-S.
Cho S.-G.
Park K.S.
Kang S.-R.
Kim J.
Song H.-C.
Kwon S.Y.
Nuclear Medicine and Molecular Imaging, 2016, 50 (4) : 329 - 336
[45] Primary papillary thyroid carcinoma previously treated incompletely with radiofrequency ablation
Kim, Hoon Yub
Ryu, Woo Sang
Woo, Sang Uk
Son, Gil Soo
Lee, Eun Sook
Lee, Jae Bok
Bae, Jeoung Won
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2010, 6 (03) : 310 - 312
[46] The effects of iodine 131 treatment on chromosomal and oxidative DNA damage in papillary thyroid carcinoma
Bitgen, Nazmiye
Bayram, Fahri
Hamurcu, Zuhal
Baskol, Gulden
Ozturk, Figen
Abdulrezzak, Ummuhan
Donmez-Altuntas, Hamiyet
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2024, 898
[47] Dasatinib-responsive Chronic Lymphocytic Leukemia in a Patient Treated for Coexisting Chronic Myeloid Leukemia
Nagao, Takayo
Takahashi, Naoto
Kameoka, Yoshihiro
Noguchi, Shinsuke
Shinohara, Yoshinori
Ohyagi, Hideaki
Kume, Masaaki
Sawada, Kenichi
INTERNAL MEDICINE, 2013, 52 (22) : 2567 - 2571
[48] Pregnancy in chronic myeloid leukemia patients treated with alpha interferon
Al Bahar, S
Pandita, R
Nath, SV
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2004, 85 (03) : 281 - 282
[49] Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study
Kwon, Seong Young
Kim, Myoung Hyoun
Kong, Eunjung
Chong, Ari
Yoo, Su Woong
Jeon, Subin
Park, Soon-Ah
Kim, Dae-Weung
Kang, Su Hwan
Choi, Jung Eun
Ha, Jung-Min
Jeong, Shin Young
Lee, Sang-Woo
CLINICAL ENDOCRINOLOGY, 2021, 95 (06) : 901 - 908
[50] Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma
Park H.J.
Jeong G.-C.
Kwon S.Y.
Min J.-J.
Bom H.-S.
Park K.S.
Cho S.-G.
Kang S.-R.
Kim J.
Song H.-C.
Chong A.
Yoo S.W.
Nuclear Medicine and Molecular Imaging, 2014, 48 (4) : 255 - 261

← 1 2 3 4 5 →